| Primary |
| Drug Use For Unknown Indication |
85.7% |
| Pulmonary Arterial Hypertension |
14.3% |
|
| Subcutaneous Abscess |
100.0% |
|
| Secondary |
| Osteoporosis Postmenopausal |
53.8% |
| Osteoarthritis |
15.4% |
| Drug Use For Unknown Indication |
7.7% |
| Blood Cholesterol Increased |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Depression |
3.8% |
| Osteoporosis |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Pulmonary Arterial Hypertension |
3.8% |
|
| Small Intestinal Obstruction |
36.4% |
| Subcutaneous Abscess |
18.2% |
| Blood Pressure Increased |
9.1% |
| Death |
9.1% |
| Haemoglobin Decreased |
9.1% |
| Nausea |
9.1% |
| Peptic Ulcer Haemorrhage |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.0% |
| Drug Use For Unknown Indication |
24.2% |
| Hypertension |
7.0% |
| Osteoporosis |
5.9% |
| Rheumatoid Arthritis |
5.5% |
| Pain |
2.7% |
| Multiple Myeloma |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Arthritis |
2.5% |
| Prophylaxis |
2.3% |
| Blood Cholesterol Increased |
2.3% |
| Depression |
2.3% |
| Supplementation Therapy |
2.1% |
| Nausea |
2.0% |
| Diabetes Mellitus |
2.0% |
| Hypercalcaemia |
1.9% |
| Muscle Spasms |
1.6% |
| Asthma |
1.6% |
| Atrial Fibrillation |
1.5% |
| Vitamin Supplementation |
1.4% |
|
| Vomiting |
19.5% |
| Weight Decreased |
9.5% |
| Weight Increased |
6.8% |
| Pain |
6.0% |
| Nausea |
5.4% |
| Pain In Extremity |
5.4% |
| Urinary Tract Infection |
5.4% |
| Pruritus |
5.1% |
| Vision Blurred |
3.8% |
| Death |
3.5% |
| Myocardial Infarction |
3.3% |
| Pulmonary Embolism |
3.3% |
| Wheezing |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| X-ray Abnormal |
3.3% |
| Tremor |
3.0% |
| Dyspnoea |
2.7% |
| Thrombocytopenia |
2.7% |
| Chest Pain |
2.4% |
| Diarrhoea |
2.4% |
|
